Home/NeoImmuneTech/Se Hwan Yang, Ph.D.

SH

Se Hwan Yang, Ph.D.

Founder, President & CEO

Therapeutic Areas

Oncology Infectious Diseases

NeoImmuneTech Pipeline

Drug	Indication	Phase
NT-I7 (efineptakin alfa)	Solid Tumors (combo with anti-PD-1)	Phase 1b/2

Leadership Team at NeoImmuneTech

NgocDiep Le, M.D., Ph.D.

EVP & Chief Medical Officer

Chief Operating Officer

View full NeoImmuneTech profile